The trademark application LEMNI was filed by Seqirus Inc., a U.S. corporation (the "Applicant"). Application withdrawn.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Vaccines
Vaccine adjuvants
Medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders
MRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses and respiratory disorders
Lipid nanoparticles for pharmaceutical, medical or diagnostic purposes
Drug carriers for medical use, namely, lipid nanoparticles for delivering drugs
Lipid nanoparticles for drug delivery sold as an integral component of drugs
Pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells.